Symbols

PULM

Pulmatrix·NASDAQ

--(--)

PULM Profile

Pulmatrix, Inc.

A clinical-stage biopharmaceutical company that developing innovative inhaled therapies to treat and prevent the spread of infectious and progressive respiratory diseases

Industry

Pharmaceutical

Established Date

Listing Date

03/21/2014

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.pulmatrix.com

Security Type

Common stock

Office address

945 Concord Street, Suite 1217, Framingham, MA 01701

Business

Introduction

Pulmatrix, Inc., was incorporated as a Delaware corporation in 2013. The Company is a biopharmaceutical company focused on developing inhaled therapeutic products for central nervous system diseases and respiratory diseases using its patented iSPERSE dry powder delivery technology.